Immix Biopharma (IMMX) Retained Earnings (2020 - 2026)
Immix Biopharma's (IMMX) quarterly Retained Earnings came in at -$114.5 million in Q1 2026, down 43.97% year-on-year from -$204.4 million in Q1 2025, and down 190508.86% quarter-over-quarter from $60160.0 in Q4 2025.
Immix Biopharma (IMMX) Retained Earnings (2020 - 2026) Analysis & Trends
Immix Biopharma has disclosed Retained Earnings across 7 years of filings, most recently posting -$114.5 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$114.5 million, down 43.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$114.5 million (down 43.97% YoY), and the FY2025 annual result was $60160.0, up 5796.97% from the prior year.
- Retained Earnings came in at -$114.5 million for Q1 2026 at Immix Biopharma, down from $60160.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $192051.0 in Q3 2024 to a low of -$114.5 million in Q1 2026.
- The 5-year median for Retained Earnings is -$1056.0 (2024), against an average of -$30.9 million.
- Peak annual rise in Retained Earnings reached 5796.97% in 2025, while the deepest fall reached 88888.8% in 2025.
- Immix Biopharma's Retained Earnings stood at $87021.0 in 2022, then plunged by 61477.48% to -$53.4 million in 2023, then surged by 100.0% to -$1056.0 in 2024, then jumped by 5796.97% to $60160.0 in 2025, then sank by 190508.86% to -$114.5 million in 2026.
- The last three Retained Earnings figures came in at -$114.5 million (Q1 2026), $60160.0 (Q4 2025), and -$93.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -838.07 Mn |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | -114.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -114.55 Mn |
| Dec 31, 2025 | 60,160.00 |
| Sep 30, 2025 | -93.78 Mn |
| Jun 30, 2025 | 65,032.00 |
| Mar 31, 2025 | -79.57 Mn |
| Dec 31, 2024 | -1,056.00 |
| Sep 30, 2024 | 192,051.00 |
| Jun 30, 2024 | -63.06 Mn |
| Mar 31, 2024 | 89,614.00 |
| Dec 31, 2023 | -53.41 Mn |
| Sep 30, 2023 | -48.32 Mn |
| Jun 30, 2023 | 80,882.00 |
| Mar 31, 2023 | -40.46 Mn |
| Dec 31, 2022 | 87,021.00 |
| Sep 30, 2022 | 62,055.00 |
| Jun 30, 2022 | -32.65 Mn |
| Mar 31, 2022 | 140,995.00 |
| Dec 31, 2021 | 125,408.00 |
| Dec 31, 2020 | 131,861.00 |